Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- ‘Pathbreaking’ osteoporosis therapy offers new option, but treatment challenges remain
-
- FDA expedites new insulin pump technology with device approvals
- Gestational diabetes has long-term CV implications
- Bariatric surgery for diabetes requires lifelong nutrition follow-up Susan Weiner, MS, RDN, CDN, CDCES, FADCES
- Diabetes camp confers psychosocial benefits for children, caregivers
- Endogenous testosterone may influence cardiovascular health in men
- Exenatide enhances in-hospital glycemic control
- GH therapy improves emotional, social quality of life in children with short stature
- One-third of adults with acromegaly make medication dosing errors
-
- Osteoporosis treatment suboptimal in men, black adults
- Bempedoic acid shows promise for LDL lowering in high-risk patients
- Genomics discoveries reveal clues to preventing, treating endocrine diseases
- Smartphone heart rate tech, deep learning may aid in diabetes detection
- Technology snags may limit adoption of current hybrid closed-loop insulin delivery system
- Verified meal, sleep window research explores meal timing as weight-loss strategy
- VIDEO: Growth hormone supplementation may contribute to successful pregnancy for women with hypopituitarism
- Are osteoporosis medications associated with improved mortality rates?
-